GeneQuine Biotherapeutics GmbH

GeneQuine Biotherapeutics is a Hamburg, Germany-based biotech company focused on improving the mobility and quality of life of patients with osteoarthritis. GeneQuine employs the latest knowledge and technology in the field to develop innovative gene therapy based drugs, which provide long-lasting effective and safe treatment of osteoarthritis. The first drug candidate is developed for horses while the long-term goal is the development of a drug for osteoarthritis in man.